CLOBETASOL for Psoriasis: Side Effects & Safety Data
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
There are 3,133 adverse event reports in the FDA FAERS database where CLOBETASOL was used for Psoriasis.
Most Reported Side Effects for CLOBETASOL
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Drug ineffective | 3,217 | 41.2% | 17 | 109 |
| Psoriasis | 1,317 | 16.9% | 1 | 23 |
| Product use in unapproved indication | 706 | 9.0% | 20 | 52 |
| Pruritus | 697 | 8.9% | 0 | 37 |
| Therapeutic product effect incomplete | 643 | 8.2% | 2 | 26 |
| Skin exfoliation | 550 | 7.1% | 0 | 45 |
| Off label use | 540 | 6.9% | 20 | 79 |
| Treatment failure | 535 | 6.9% | 0 | 12 |
| Erythema | 464 | 5.9% | 1 | 40 |
| Arthralgia | 417 | 5.3% | 0 | 12 |
| Rash | 335 | 4.3% | 2 | 31 |
| Condition aggravated | 297 | 3.8% | 4 | 28 |
| Drug ineffective for unapproved indication | 248 | 3.2% | 2 | 19 |
| Psoriatic arthropathy | 240 | 3.1% | 0 | 2 |
| Papule | 234 | 3.0% | 0 | 2 |
Other Indications for CLOBETASOL
Product used for unknown indication (1,413)
Eczema (304)
Psoriatic arthropathy (229)
Pemphigoid (225)
Pruritus (175)
Dermatitis atopic (145)
Rash (143)
Lichen sclerosus (117)
Alopecia (98)
Pyoderma gangrenosum (68)
Other Drugs Used for Psoriasis
APREMILAST (76,127)
SECUKINUMAB (58,471)
ADALIMUMAB (56,634)
RISANKIZUMAB-RZAA (40,890)
ETANERCEPT (30,483)
USTEKINUMAB (21,763)
IXEKIZUMAB (16,569)
GUSELKUMAB (11,736)
CERTOLIZUMAB PEGOL (8,179)
METHOTREXATE (6,628)